Ibex Technologies (TSXV:IBT) Total Liabilities : C$3.00 Mil (As of Jan. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Total Liabilities?

Ibex Technologies's Total Liabilities for the quarter that ended in Jan. 2024 was C$3.00 Mil.

Ibex Technologies's quarterly Total Liabilities increased from Jul. 2023 (C$3.22 Mil) to Oct. 2023 (C$3.54 Mil) but then declined from Oct. 2023 (C$3.54 Mil) to Jan. 2024 (C$3.00 Mil).

Ibex Technologies's annual Total Liabilities increased from Jul. 2021 (C$2.19 Mil) to Jul. 2022 (C$3.23 Mil) but then declined from Jul. 2022 (C$3.23 Mil) to Jul. 2023 (C$3.22 Mil).

Ibex Technologies Total Liabilities Historical Data

The historical data trend for Ibex Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Total Liabilities Chart

Ibex Technologies Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Total Liabilities

Get a 7-Day Free Trial

1.81

1.47

2.19

3.23

3.22

Ibex Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Liabilities	Get a 7-Day Free Trial															2.68	2.68	3.22	3.54	3.00

Ibex Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ibex Technologies's Total Liabilities for the fiscal year that ended in Jul. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.798	+	(1.426	+	2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.22

Total Liabilities	=	Total Assets (A: Jul. 2023 )	-	Total Equity (A: Jul. 2023 )
	=	16.831	-	13.607
	=	3.22

Ibex Technologies's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.685	+	(1.313	+	-0.0010000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.00

Total Liabilities	=	Total Assets (Q: Jan. 2024 )	-	Total Equity (Q: Jan. 2024 )
	=	17.228	-	14.231
	=	3.00

Ibex Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibex Technologies (TSXV:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

IBXNF:USA IBT:Germany

Address

5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7

Website

https://www.ibex.ca

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines